Robert B Bazemore insider trades

Open-market stock purchases and sales by Robert B Bazemore, Director at Ardelyx, Inc, from SEC Form 4 filings since Sep 23, 2014.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -31%.

Recent trades

DateStockTradeValue
Jun 16, 2026ARDX Ardelyx, IncBought (not open market)—
Jun 16, 2026ARDX Ardelyx, IncBought (not open market)—
May 21, 2026NUVB Nuvation Bio IncBought (not open market)—
Dec 16, 2025AKTX Akari Therapeutics plcBought$50K
Dec 16, 2025AKTX Akari Therapeutics plcBought$12.5K

Companies traded

  • ARDX Ardelyx, Inc: other filings, last Jun 16, 2026
  • NUVB Nuvation Bio Inc: 1 buy, last May 21, 2026
  • AKTX Akari Therapeutics plc: 2 buys, last Dec 16, 2025
  • EPZM Epizyme, Inc: 9 sales, last Mar 25, 2021
  • NTGN Neon Therapeutics, Inc: other filings, last May 6, 2020
  • GEVA Synageva Biopharma Corp: other filings, last Jun 22, 2015

Get free alerts when Robert B Bazemore files a new trade →